Insider · CIK 0001653008

Macdonald R. Loch

Reports to the SEC for 2 companies · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001653008

Forms 4 and 5

Insider transactions

24 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-28	GRCEGrace Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+54.7K sh	—	—	54,690
2025-04-14	GRCEGrace Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+40K sh	—	—	40,000
2024-05-06	GRCEGrace Therapeutics, Inc. · Stock Options (Right to Buy)A Award	Chief Medical Officer	AAward	+25.4K sh	—	—	25,380
2023-07-14	GRCEGrace Therapeutics, Inc. · Stock Options (Right to Buy)A Award	Chief Medical Officer	AAward	+60K sh	—	—	60,000
2019-03-15	PDSBPDS Biotechnology CorpM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	—	—	580,602
2019-03-15	PDSBPDS Biotechnology Corp · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2018-08-14	PDSBPDS Biotechnology Corp · Restricted Stock UnitsA Award	Director	AAward	+10K sh	—	—	10,000
2018-06-19	PDSBPDS Biotechnology Corp · Stock Option (Right To Purchase)A Award	Director	AAward	+20K sh	—	—	20,000
2018-03-22	PDSBPDS Biotechnology CorpS Sale	Director	SSale	−2,500 sh	$16.41	−$41K	570,602
2018-03-21	PDSBPDS Biotechnology CorpS Sale	Director	SSale	−2,500 sh	$16.52	−$41.3K	573,102
2018-03-20	PDSBPDS Biotechnology CorpS Sale	Director	SSale	−5,000 sh	$16.47	−$82.4K	575,602
2018-03-19	PDSBPDS Biotechnology CorpS Sale	Director	SSale	−2,500 sh	$16.66	−$41.7K	580,602
2018-02-22	PDSBPDS Biotechnology CorpS Sale	Director	SSale	−2,500 sh	$14.49	−$36.2K	583,102
2018-02-21	PDSBPDS Biotechnology CorpS Sale	Director	SSale	−5,000 sh	$13.82	−$69.1K	585,602
2018-02-20	PDSBPDS Biotechnology CorpS Sale	Director	SSale	−5,000 sh	$13.75	−$68.8K	590,602
2017-03-13	PDSBPDS Biotechnology Corp · Stock Option (right To Purchase)A Award	Director	AAward	+110K sh	$8.86	+$975K	110,000
2017-01-23	PDSBPDS Biotechnology CorpM Exercise/Conversion	Director	MExercise/Conversion	+25K sh	$2.04	+$51K	595,602
2017-01-23	PDSBPDS Biotechnology Corp · Stock Option (right To Purchase)M Exercise/Conversion	Director	MExercise/Conversion	−25K sh	—	—	75,504
2016-02-16	PDSBPDS Biotechnology Corp · Stock Option (Right to Purchase)A Award	Director	AAward	+85K sh	—	—	85,000
2015-10-06	PDSBPDS Biotechnology CorpC Conversion	Director	CConversion	+18.3K sh	—	—	566,480
2015-10-06	PDSBPDS Biotechnology CorpC Conversion	Director	CConversion	+3,928 sh	—	—	570,408
2015-10-06	PDSBPDS Biotechnology CorpJ Other	Director	JOther	+194 sh	$7.90	+$1,532.6	570,602
2015-10-06	PDSBPDS Biotechnology Corp · Series A Convertible Preferred StockC Conversion	Director	CConversion	−25K sh	—	—	0
2015-10-06	PDSBPDS Biotechnology Corp · Series C-1 Convertible Preferred StockC Conversion	Director	CConversion	−5,373 sh	—	—	0

Recent filings

Accepted (ET)
Sep 14
Macdonald R. Loch0001140361-26-035317
SEC(opens sec.gov)
Apr 164
Macdonald R. Loch0001140361-25-014265
SEC(opens sec.gov)
May 84
Macdonald R. Loch0000950170-24-056083
SEC(opens sec.gov)
Jul 184
Macdonald R. Loch0001062993-23-014997
SEC(opens sec.gov)
Mar 184
Macdonald R. Loch0001127602-19-011943
SEC(opens sec.gov)
Aug 154
Macdonald R. Loch0001127602-18-025379
SEC(opens sec.gov)
Jun 204
Macdonald R. Loch0001127602-18-021589
SEC(opens sec.gov)
Mar 224
Macdonald R. Loch0001127602-18-012504
SEC(opens sec.gov)
Mar 214
Macdonald R. Loch0001127602-18-012359
SEC(opens sec.gov)
Feb 224
Macdonald R. Loch0001127602-18-007774
SEC(opens sec.gov)
Mar 154
Edge Therapeutics, Inc.0001127602-17-011770
SEC(opens sec.gov)
Jan 254
Edge Therapeutics, Inc.0001127602-17-002309
SEC(opens sec.gov)
Feb 184
Edge Therapeutics, Inc.0001140361-16-054010
SEC(opens sec.gov)
Oct 84
Edge Therapeutics, Inc.0001140361-15-037184
SEC(opens sec.gov)

Companies

Address

C/O GRACE THERAPEUTICS, INC. 103 CARNEGIE CENTER, SUITE 300

PRINCETON, NJ, 08540